Kenneth Lin

Kenneth Lin

Director/Board Member presso ANEBULO PHARMACEUTICALS, INC.

Patrimonio netto: - $ in data 31/03/2024

51 anni
Finance
Health Technology
Consumer Services

Profilo

Kenneth S.
Lin
was the founder of Ab Initio Biotherapeutics, Inc. founded in 2015, where he held the position of President & Chief Executive Officer until 2019.
Currently, he is an Independent Director at Anebulo Pharmaceuticals, Inc. since 2021 and an Advisor at Tarrant Capital IP LLC since 2008.
Dr. Lin's former positions include Director at Vibrynt, Inc. and Conventus Orthopaedics, Inc., VP-Corporate Development & Investor Relations at Ulthera, Inc. from 2012 to 2014, Research Associate at Goldman Sachs & Co. LLC from 2000 to 2002, Associate at J.P.
Morgan Partners LLC and Panorama Capital LLC, and Vice President at TPG, Inc. from 2008 to 2012.
Dr. Lin's education includes an undergraduate degree from Stanford University in 1994 and a doctorate degree from Case Western Reserve University in 1999.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
30/09/2023 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Kenneth Lin

SocietàPosizioneInizio
ANEBULO PHARMACEUTICALS, INC. Director/Board Member 01/02/2021
Corporate Officer/Principal 13/06/2012
Tutte le posizioni attive di Kenneth Lin

Precedenti posizioni note di Kenneth Lin

SocietàPosizioneFine
Chief Executive Officer 01/07/2019
Investor Relations Contact 01/07/2014
TPG INC. Corporate Officer/Principal 01/06/2012
Corporate Officer/Principal 31/12/2007
Analyst-Equity 31/12/2002
Vedi nel dettaglio l'esperienza di Kenneth Lin

Formazione di Kenneth Lin

Stanford University Undergraduate Degree
Case Western Reserve University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kenneth Lin

Relazioni

100 +

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
ANEBULO PHARMACEUTICALS, INC.

Health Technology

TPG INC.

Finance

Aziende private8

Health Technology

Health Technology

Health Services

Finance

Finance

Finance

Finance

Health Technology

Vedi le connessioni aziendali